Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Metrics Expands Capabilities | Contract Pharma
Breaking News

Metrics Expands Capabilities

Adds liquids, creams and gels for pharma applications

Metrics Inc. has added capabilities to produce non-sterile liquids, creams and gels for a broad range of pharmaceutical applications. Metrics can manage the formulation development of new products or the technology transfer of existing products for manufacturing and packaging, as well as provide any necessary lab support services.
 
The company’s cream suite can manufacture two- and three-phase suspensions and emulsions, including pastes, creams, lotions and gels. Its two modular filling lines and its liquid processing equipment can produce batch sizes ranging from 250 to 2,000 kilograms. The liquid suite can manufacture bulk liquids, including mouthwash, antiseptics, elixirs and suspensions. A flame-proofed area also is available for processing flammable liquids. The suite’s four liquid manufacturing vessels produce batch sizes ranging from 350 to 6,000 liters.
 
“The addition of liquids, creams and gels to Metrics’ portfolio of capabilities is just the latest chapter in what has been our tale from the start – delivering demonstrated scientific and operational excellence in response to our clients’ growing and changing needs,” said Phil Hodges, president. “It is an honor to serve our clients in this new way and, hopefully, continue to build upon our long-time relationships based on mutual trust and respect.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters